Vilmarie Rodriguez

Correction to: Leukemia (2018); published online 28 September 2018 In the original version of this Article the following authors were omitted: • Claudia Rossig (University Children’s Hospital of Münster, Münster, Germany) • Paul Schlegel (University Children’s Hospital of Würzburg, Würzburg, Germany) • Jean-Pierre Bourquin (University Children’s Hospital, Switzerland) • Aurelie Cabannes (University Hospital Saint-Louis, Paris, France) • Luciano Dalla-Pozza (Children’s Hospital at Westmead,...

From the approximately 100 children treated via the compassionate access program, we obtained data on 51 patients, ages 2.2 years to 21.3 years (median 11.5 years) who received InO from January 2013 to December 2016 at 30 pediatric oncology centers in North America, Europe, and Australia. All but three patients received InO in 2015 or 2016. Detailed patient characteristics are listed in Table 1. Four patients had Down syndrome.

Contributors JMD: Involved in planning, data acquisition and analysis and interpretation of data for the article. Involved in drafting, editing and revising the article critically for important intellectual content. Gives full final approval of the version submitted. Agrees to be accountable for the article and to ensure that all questions regarding accuracy or integrity are investigated and resolved.